{"count": 4, "results": [{"_id": "33546161", "pmid": 33546161, "pmcid": "PMC7913128", "title": "A Multi-Objective Approach for Drug Repurposing in Preeclampsia", "journal": "Molecules", "authors": ["Tejera E", "Pérez-Castillo Y", "Chamorro A", "Cabrera-Andrade A", "Sanchez ME"], "date": "2021-02-03T00:00:00Z", "doi": "10.3390/molecules26040777", "meta_date_publication": "2021 Feb 3", "meta_volume": "26", "meta_issue": "4", "meta_pages": "", "score": 50269.39, "text_hl": "On the other hand, even when the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ during @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@preeclampsia@@@ in unknown, a close statin (@CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@) is known to reduce the @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ associated with @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@preeclampsia@@@. ", "citations": {"NLM": "Tejera E, Pérez-Castillo Y, Chamorro A, Cabrera-Andrade A, Sanchez ME. A Multi-Objective Approach for Drug Repurposing in Preeclampsia Molecules. 2021 Feb 3;26(4):. PMID: 33546161", "BibTeX": "@article{33546161, title={A Multi-Objective Approach for Drug Repurposing in Preeclampsia}, author={Tejera E and Pérez-Castillo Y and Chamorro A and Cabrera-Andrade A and Sanchez ME}, journal={Molecules}, volume={26}, number={4}}"}}, {"_id": "32199147", "pmid": 32199147, "title": "Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction.", "journal": "Pregnancy Hypertens", "authors": ["de Alwis N", "Beard S", "Mangwiro YT", "Binder NK", "Kaitu'u-Lino TJ", "Brownfoot FC", "Tong S", "Hannan NJ"], "date": "2020-04-01T00:00:00Z", "doi": "10.1016/j.preghy.2020.03.004", "meta_date_publication": "2020 Apr", "meta_volume": "20", "meta_issue": "", "meta_pages": "83-91", "score": 50262.65, "text_hl": "This study aimed to evaluate the ability of @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ to reduce @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@pre-eclampsia@@@-associated markers of @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in @SPECIES_9606 @@@human@@@ endothelial cells. ", "citations": {"NLM": "de Alwis N, Beard S, Mangwiro YT, Binder NK, Kaitu'u-Lino TJ, Brownfoot FC, Tong S, Hannan NJ. Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction. Pregnancy Hypertens. 2020 Apr;20():83-91. PMID: 32199147", "BibTeX": "@article{32199147, title={Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction.}, author={de Alwis N and Beard S and Mangwiro YT and Binder NK and Kaitu'u-Lino TJ and Brownfoot FC and Tong S and Hannan NJ}, journal={Pregnancy Hypertens}, volume={20}, pages={83-91}}"}}, {"_id": "27856999", "pmid": 27856999, "title": "Simvastatin Alleviates Pathology in a Rat Model of Preeclampsia Involving ERK/MAPK Pathway.", "journal": "Reprod Sci", "authors": ["Dong X", "Shi D"], "date": "2017-07-01T00:00:00Z", "doi": "10.1177/1933719116678693", "meta_date_publication": "2017 Jul", "meta_volume": "24", "meta_issue": "7", "meta_pages": "1053-1061", "score": 50064.938, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Alleviates Pathology in a @SPECIES_10116 @@@Rat@@@ Model of @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@Preeclampsia@@@ Involving @GENE_EPHB1 @GENE_24338 @@@ERK@@@/MAPK Pathway.", "citations": {"NLM": "Dong X, Shi D. Simvastatin Alleviates Pathology in a Rat Model of Preeclampsia Involving ERK/MAPK Pathway. Reprod Sci. 2017 Jul;24(7):1053-1061. PMID: 27856999", "BibTeX": "@article{27856999, title={Simvastatin Alleviates Pathology in a Rat Model of Preeclampsia Involving ERK/MAPK Pathway.}, author={Dong X and Shi D}, journal={Reprod Sci}, volume={24}, number={7}, pages={1053-1061}}"}}, {"_id": "26556031", "pmid": 26556031, "title": "Simvastatin inhibits oxidative stress via the activation of nuclear factor erythroid 2-related factor 2 signaling in trophoblast cells.", "journal": "J Obstet Gynaecol Res", "authors": ["Chigusa Y", "Kawasaki K", "Kondoh E", "Mogami H", "Ujita M", "Fujita K", "Tatsumi K", "Takeda S", "Konishi I"], "date": "2016-01-01T00:00:00Z", "doi": "10.1111/jog.12876", "meta_date_publication": "2016 Jan", "meta_volume": "42", "meta_issue": "1", "meta_pages": "36-43", "score": 50055.477, "text_hl": "CONCLUSION: @DISEASE_Hypoxia @DISEASE_MESH:D000860 @@@Hypoxia@@@ is one of the important negative regulators of @GENE_NFE2L2 @GENE_4780 @@@Nrf2@@@ activation, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ inhibits oxidative stress through the activation of @GENE_NFE2L2 @GENE_4780 @@@Nrf2@@@ signaling in trophoblasts, indicating the potential therapeutic role of statin for @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@pre-eclampsia@@@.", "citations": {"NLM": "Chigusa Y, Kawasaki K, Kondoh E, Mogami H, Ujita M, Fujita K, Tatsumi K, Takeda S, Konishi I. Simvastatin inhibits oxidative stress via the activation of nuclear factor erythroid 2-related factor 2 signaling in trophoblast cells. J Obstet Gynaecol Res. 2016 Jan;42(1):36-43. PMID: 26556031", "BibTeX": "@article{26556031, title={Simvastatin inhibits oxidative stress via the activation of nuclear factor erythroid 2-related factor 2 signaling in trophoblast cells.}, author={Chigusa Y and Kawasaki K and Kondoh E and Mogami H and Ujita M and Fujita K and Tatsumi K and Takeda S and Konishi I}, journal={J Obstet Gynaecol Res}, volume={42}, number={1}, pages={36-43}}"}}]}